Notes to the consolidated financial statements 28 Share-based payments During the year to 31 March 2008, various equity-settled share-based payment arrangements existed, which are described below: Sharesave scheme Deferred Performance Executive share bonus Duration Type of arrangement share plan option scheme share plan in years Timing of grant Bi-annually Annually in June Annually in July Annually in June Annually in in June and note a December November Number of options shares granted in year to 31 March 2008 1 511 463 429 612 3 102 128 215 130 5 57 335 104 183 Number of options shares granted in year to 31 March 2007 1 923 730 324 828 3 58 956 59 496 5 49 899 34 329 Fair value per share for 2008 grant p 141 194 3 120 97 5 138 105 Fair value per share for 2007 grant p 277 287 3 127 158 5 160 204 Valuation basis Monte Carlo Binomial Lattice Monte Carlo Black-Scholes Black-Scholes Contractual life 10 years 10 years 3 years 3 5 years 3 5 years Vesting conditions note b note c note d note e note e a The last grant under this scheme was made in June 2004. b Exercise is dependent on total shareholder return as measured by reference to a comparator group over a three-year period following grant.
Participants are not entitled to dividends prior to the exercise of options.
c Exercise is dependent on earnings per share performance relative to inflation over a three-year period following grant.
d Executives have the opportunity to defer up to 50% of their annual cash bonus after deduction of tax, national insurance or other social security payment and invest the amount deferred in the Companys shares.
Subject to the satisfaction of employment conditions and a performance target over the performance period, participants will receive awards of matching shares based on the number of shares which could have been acquired from the gross bonus amount deferred by the participant.
During the performance period, dividends are paid on the deferred shares but not on matching shares.
Further details are set out in the directors remuneration report on page 85. e Options granted in the years to 31 March 2007 and 31 March 2008 were by invitation at a 10% discount to the market price.
Options are exercisable at the end of a three-year or five-year savings contract.
The Group recognised total expenses of 5 million 2007 6 million related to equity-settled share-based payment transactions during the year.
Details of the movements for equity-settled share option schemes during the year to 31 March were as follows: 2008 2007 Weighted Weighted average average exercise exercise price price Number pence Number pence Outstanding at 1 April 14 119 821 164 16 942 061 230 Granted 2 419 851 87 2 451 238 50 Exercised 3 929 906 233 5 043 739 263 Lapsed 864 360 315 229 739 294 Outstanding at 31 March 11 745 406 104 14 119 821 164 Tate & Lyle Annual Report 2008 133 STATUTORY INFORMATION HOW WE RUN THE BUSINESS HOW WE PERFORMED WHAT WE DO OVERVIEW OF THE YEAR Notes to the consolidated financial statements 28 Share-based payments continued The weighted average Tate & Lyle PLC share price at the date of exercise for share options exercised during the year was 551 pence 2007 670 pence.
At 31 March 2008, 3,346,475 2007 2,874,160 of the outstanding options were exercisable at a weighted average exercise price of 328 pence 2007 219 pence.
A detailed breakdown of the range of exercise prices for options outstanding at 31 March is shown in the table below: 2008 2007 Weighted Weighted Weighted Weighted average average average average Number remaining exercise Number remaining exercise outstanding contractual price outstanding contractual price at end of year life in months pence at end of year life in months pence At nil cost 7 729 733 53.7 7 277 251 99.5 0.01 to 1.99 51 083 17.0 182 2.00 to 3.99 3 711 091 64.7 289 6 239 844 76.2 325 4.00 to 7.99 304 582 26.6 482 551 643 39.6 487 Total 11 745 406 56.5 104 14 119 821 86.6 164 The fair value of grants is measured using the valuation technique that is considered to be the most appropriate to value each class of grant.
These include Binomial Lattice models, Black-Scholes calculations and Monte Carlo simulations.
These valuations take into account factors such as non-transferability, exercise restrictions and behavioural considerations.
Key assumptions are detailed below: Sharesave Sharesave Deferred Performance scheme scheme At 31 March 2008 bonus plan share plan June December Expected volatility 25% 25% 25% 30% Expected life n a n a 3.5 5.5 years 3.5 5.5 years Risk-free rate n a n a 6.0% 5.9% 4.5% 4.6% Expected dividend yield 3.6% 3.5% 3.8% 4.9% Forfeiture rate 0% 0% 10% 10% Correlation with comparators 20% 20% n a n a Volatility of comparators 5-47% 5-47% n a n a Expectations of meeting performance criteria 100% 100% n a n a Weighted average market price at date of grant p 568 576 531 439 Deferred Performance Sharesave At 31 March 2007 bonus plan share plan scheme Expected volatility 20% 20% 22% Expected life n a n a 3.5 5.5 years Risk-free rate n a n a 4.9% Expected dividend yield 3.3% 3.4% 3.3% Forfeiture rate 0% 0% 10% Correlation with comparators 20% 20% n a Volatility of comparators 8-52% 8-52% n a Expectations of meeting performance criteria 100% 100% n a Weighted average market price at date of grant p 590 581 695 The expected volatility is based on the Companys historical volatility over the three-year period prior to each award date.
